Patents by Inventor Marcel Mulbaier

Marcel Mulbaier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMIDAZO [1,2-a]PYRIDINE COMPOUNDS FOR USE IN THERAPY
    Publication number: 20140221354
    Abstract: The present invention provides novel imidazo[1,2-a]pyridine compounds that are useful in therapy of diseases and disorders. The novel compounds inhibit the activation of Hypoxia Inducible Factor (HIF)-mediated transcription and signaling under hypoxic conditions. In one aspect, the compounds of the present invention are useful for the preparation of a medicament for the treatment or prevention of a disease or disorder selected from the group consisting of an inflammatory disease, a hyperproliferative disease or disorder, a hypoxia-related pathology and a disease characterized by excessive vascularization.
    Type: Application
    Filed: March 31, 2011
    Publication date: August 7, 2014
    Applicant: EMBLEM Technology Transfer GmbH
    Inventors: Marcel Mulbaier, Jorge Alonso, Douglas Thomson, Bernd Janssen, Arantxa Encinas Lopez, Bernd Wendt, Christoph Schultes
  • Method for producing albumin conjugates containing gyrase inhibitors
    Patent number: 7803791
    Abstract: The present invention is directed to a Gyrase inhibitor-protein conjugate; in particular a Gyrase inhibitor-albumin conjugate. The present invention further provides methods of the treatment of inflammatory conditions and tumors. Methods of making and producing a Gyrase inhibitor-protein conjugate are also disclosed.
    Type: Grant
    Filed: January 20, 2006
    Date of Patent: September 28, 2010
    Assignee: Albupharm Heidelberg GmbH & Co. KG
    Inventors: Hannsjörg Sinn, Marcel Mülbaier
  • Method For The Production Of Albumen Conjugates With Non-Steroidal Antirheumatic Drugs (Nsar)
    Publication number: 20080306245
    Abstract: The present invention concerns NSAR (non-steroidal antirheumatic agents)-protein conjugates and in particular NSAR-albumin conjugates, processes for their production and their use as pharmaceutical preparations especially for treating inflammations.
    Type: Application
    Filed: November 25, 2005
    Publication date: December 11, 2008
    Applicant: ALBUPHARM HEIDELBERG GMBH & CO. KG
    Inventors: Hannsjorg Sinn, Marcel Mulbaier
  • Method for Producing Albumin Conjugates Containing Gyrase Inhibitors
    Publication number: 20080108708
    Abstract: The present invention concerns gyrase inhibitor-protein conjugates and in particular gyrase inhibitor-albumin conjugates, pharmaceutical preparations comprising gyrase inhibitor-protein conjugates in particular for the treatment and/or prophylaxis of inflammatory processes and/or tumours as well as methods for their production.
    Type: Application
    Filed: January 20, 2006
    Publication date: May 8, 2008
    Applicant: ALBUPHARM HEIDELBERG GMBH & CO. KG
    Inventors: Hannsjorg Sinn, Marcel Mulbaier